Xeris Pharmaceuticals Inc (XERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,234 | 554 | -10,527 | -11,148 | -9,220 |
| Depreciation Amortization | 4,099 | 16,066 | 12,003 | 7,971 | 3,987 |
| Accounts receivable | -5,245 | -10,635 | -13,336 | -12,633 | -5,915 |
| Accounts payable and accrued liabilities | 4,250 | -69 | 1,629 | -367 | 4,062 |
| Other Working Capital | -603 | -10,360 | -9,987 | -16,123 | -9,241 |
| Other Operating Activity | 5,135 | 33,070 | 28,801 | 22,451 | 6,296 |
| Operating Cash Flow | $9,870 | $28,626 | $8,583 | $-9,849 | $-10,031 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -325 | -696 | -363 | -292 | -13 |
| Investing Cash Flow | $-325 | $-696 | $-363 | $-292 | $-13 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,180 | 22,265 | 20,991 | 6,663 | 4,861 |
| Common Stock Repurchased | -17,017 | -10,876 | -9,336 | -8,858 | -7,998 |
| Financing Cash Flow | $-8,837 | $11,389 | $11,655 | $-2,195 | $-3,137 |
| Beginning Cash Position | 115,063 | 75,744 | 75,744 | 75,744 | 75,744 |
| End Cash Position | 115,771 | 115,063 | 95,619 | 63,408 | 62,563 |
| Net Cash Flow | $708 | $39,319 | $19,875 | $-12,336 | $-13,181 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,870 | 28,626 | 8,583 | -9,849 | -10,031 |
| Capital Expenditure | -325 | -696 | -363 | -292 | -13 |
| Free Cash Flow | 9,545 | 27,930 | 8,220 | -10,141 | -10,044 |